Dyadic Applied BioSolutions
Dyadic Applied BioSolutions

Dyadic Applied BioSolutions

Biotechnology
WebsiteInvestor RelationsSEC
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

$17.1M

Market Cap • 9/15/2026

2002

(24 years)

Founded

2004

(22 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

—

P/S

4,5

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

—

EPS

—

Market Cap

Market Cap

17,1M

EV

17,5M

EV/Revenue

4,6

EV/EBITDA

-2,4

EV/EBIT

-2,4

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-97,5M

Profitability

Gross Margin

16,2%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

48,4%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

0,2%

% Goodwill

0%

ROE

522,6%

ROIC

—

Growth

CAGR Revenue 5Y

12%

CAGR Op. Income 5Y

-9,2%

CAGR Net Income 5Y

-8,1%

CAGR EPS 5Y

-11,3%

CAGR OCF 5Y

1,2%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

1,7

Quick Ratio

1,5

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium